STZ
33
-2
FRT
53
-3
XRX
42
-7
PFE
26
-17
GM
74
-8
PCAR
43
-5
HSIC
56
-3
QRVO
64
-5
EW
37
-9
TGNA
48
-8
CTAS
61
-3
OMC
35
-4
PRU
42
-12
CMS
54
-3
BMY
48
-3
WAT
48
-7
HST
39
-4
DGX
50
-9
DE
50
-18
SWK
42
-22
STZ
33
-2
FRT
53
-3
XRX
42
-7
PFE
26
-17
GM
74
-8
PCAR
43
-5
HSIC
56
-3
QRVO
64
-5
EW
37
-9
TGNA
48
-8
CTAS
61
-3
OMC
35
-4
PRU
42
-12
CMS
54
-3
BMY
48
-3
WAT
48
-7
HST
39
-4
DGX
50
-9
DE
50
-18
SWK
42
-22
Financhill
Back

MetLife Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Buy
66

MET
MetLife

Last Price:
$78.03
Seasonality Move:
2.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

MetLife Stock Forecast

  • Over the next 52 weeks, MetLife has on average historically risen by 10.9% based on the past 25 years of stock performance.
  • MetLife has risen higher in 17 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 68%
  • Is MetLife Stock Undervalued?
    The current MetLife [MET] share price is $77.90. The Score for MET is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • MET is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will MetLife Stock Go Up Next Year?

  • Over the next 52 weeks, MetLife has on average historically risen by 10.9% based on the past 25 years of stock performance.

MetLife Stock Rating

Buy
66
MetLife (MET) is a Buy

Is MetLife overpriced?

  • MetLife has risen higher in 17 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 68%

MetLife Stock Price History

Is MET stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MET is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Insurance
Sector:
Financials
Type:
stock
Website:
metlife.com

52-Week Data

52-Week High:
89.05
52-Week Low:
65.21

Prediction Charts

Market Cap:
52.3B
Price in USD:
77.90
Volume:
3M
Beta:
1.25

Technical Analysis

SMA50:
77.52
SMA100:
80.54
SMA200:
80.21
52-Wk Change:
7.32%

Stock Predictions

  • Is MetLife stock public?
    Yes, MetLife is a publicly traded company.
  • What is the MetLife stock quote today?
    The MetLife stock price is 77.90 USD today.
  • How to buy MetLife stock online?
    You can buy MetLife shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-2 77.07 77.81 78.15 76.28
May-5 76.95 77.41 78.16 76.95
May-6 76.29 76.42 77.37 75.95
May-7 76.96 76.74 77.64 75.92
May-8 77.60 77.59 78.93 77.05
May-9 78.06 77.85 78.54 77.69
May-12 80.24 80.64 81.05 80.10
May-13 80.58 81.16 81.86 80.58
May-14 81.15 79.95 81.33 79.74
May-15 79.50 80.46 80.56 79.11
May-16 80.49 80.83 81.08 79.96
May-19 80.30 80.87 81.10 80.00
May-20 80.69 80.33 81.09 80.12
May-21 79.86 77.90 80.22 77.85

MetLife Earnings

MetLife Earnings Report: Per Share MetLife Earnings Q1 Q2 Q3 and Q4 last year and next year.

MetLife Forecast Revenue Growth

MetLife Stock Analysis: Historical quarterly revenues per share for MetLife and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.22 per share, an increase this year of $0.99 per share, and an increase next year of $1.18 per share.

* MetLife stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.